Janus kinase inhibitor - Wikipedia
A Janus kinase inhibitor, also known as JAK inhibitor or jakinib, [1] is a type of immune modulating medication, which inhibits the activity of one or more of the Janus kinase family of enzymes …
What are JAK inhibitors and how do they work? - Drugs.com
Jul 15, 2025 · Janus kinase (JAK) inhibitors work by slowing down the overactivity of the immune system that can lead to inflammation and pain. They do this by inhibiting the activity of one or …
JAK Inhibitors: Uses, Types, Side Effects, and More
Aug 23, 2025 · In this article, learn about the dosage, uses, and ongoing research underway for JAK inhibitors available in the United States, as well as common side effects, …
List of the 9 Leading JAK Inhibitor Drugs - GoodRx
Aug 13, 2024 · JAK inhibitors like Xeljanz, Rinvoq, and Opzelura can treat inflammatory conditions and even alopecia. View this list of JAK inhibitors to learn about their various uses.
A Comprehensive Overview of Globally Approved JAK Inhibitors
Targeting the JAK family kinases with small-molecule inhibitors has proved to be effective in the treatment of different types of diseases. In the current review, eleven of the JAK inhibitors that …
What Is a Janus Kinase Inhibitor and How Does It Work?
Aug 2, 2025 · Janus Kinase inhibitors are a class of medications that modulate the body’s immune and inflammatory responses. These drugs function by targeting specific pathways within cells, …
Janus kinase inhibitors - DermNet
What are Janus kinase inhibitors? Janus kinase (JAK) inhibitors, also called jakinibs or JAKis, are small molecules that interrupt the JAK-STAT (Signal Transducer and Activator of …
JAK Inhibitors 101 - The Rheumatologist
Jul 28, 2025 · In the EULAR 2025 session, JAK It Out: New Perspectives on JAK Inhibitors, several speakers provided insights into these medications. The Basics.
Pharmaceutical aspects of JAK inhibitors: a comparative review
Dec 11, 2024 · Janus kinase inhibitors (JAKIs) are a new class of drugs used in the treatment of a heterogeneous group of diseases, mainly inflammatory and autoimmune diseases. Janus …
Pharmacological targeting of the JAK–STAT pathway: new ... - Nature
4 days ago · The Janus kinase (JAK)–signal transducer and activator of transcription (STAT) pathway mediates cellular responses to cytokines and growth factors, and its dysregulation …